‘Conspiracy’: Kerala won't protect activists led by Trupti Desai to visit Sabarimala

News Network
November 26, 2019

Kochi, Nov 26: A team of gender rights activists led by Trupti Desai, which was headed for Sabarimala to offer prayers at Lord Ayyappa temple was denied police protection on Tuesday amidst protests by devotees, members of a right wing outfit and BJP here, against their entry into the shrine.

The Kerala government dubbed Desai's attempt to visit Sabarimala as a "conspiracy".

As soon as the team of activists landed at the airport here, they went to the city police commissionerate seeking protection to proceed to the hill shrine.

However, police declined to grant protection to them, citing the recent Supreme Court decision to review its 2018 order permitting women in all age groups into Sabarimala.

A large number of Ayyappa devotees, activists of the BJP and Sabarimala Karma Samiti gathered outside the commissionerate chanting 'Ayyappa Saranam' mantra protesting against Desai's visit.

Activist from Kerala, Bindu Ammini, who had joined Desai's team at the airport was attacked by the rightwing group member using pepper spray when she came out of the office of the commissioner to take some papers from their vehicle, police sources said.

Visuals aired by TV channels showed her being attacked.

The man identified as Srinath Padmanabhan has been arrested, police said.

Ammini, who was admitted to the general hospital here, has been discharged after the treatment, her lawyer said.

The agitators ended the protest following assurances from police officials that the women activists would not be given protection to visit the temple.

Ammini and Kanakadurga were the two women activists who had offered prayers at Sabarimala Lord Ayyappa temple under police security last year following the Supreme Court permitting entry of women in all age groups into the hill shrine.

Reacting cautiously, the CPI(M)-led LDF government condemned the attack on Ammini but made it clear that no women in the age group of 10 and 50 would be given police protection to climb the holy hills unless they get an order from the Supreme Court in this regard.

Kerala Devaswom Minister Kadakampally Surendran alleged conspiracy behind women's rights activist Trupti Desai's decision to visit Sabarimala.

"The government suspects a conspiracy behind Trupti Desai's decision to go to Sabarimala. She has come from Pune, a stronghold of the RSS and the BJP," the Minister told reporters in Thalassery.

Surendran alleged the move was to create trouble during a peaceful pilgrim season in Sabarimala.

Travancore Devaswom Board president N Vasu said the board was not informed about their plan to visit the temple.

Contending that the apex court has not stayed its 2018 order permitting women in the menstrual age group into the shrine, Ammini said theywould file a contempt of court petition in the top court against the state government for not providing them police security to visit the temple.

Congress leader Abhishek Manu Singhvi, who argued the Sabarimala case in the Supreme Court, said the likes of Desai can only do excesses in the name of activism while the final verdict for Sabarimala temple was still pending before the apex court.

"At least the sentiment of people associated with the temple must be respected before final verdict assigns rights," he said in a tweet.

Leader of Opposition in Kerala Assembly, Ramesh Chennithala, alleged "conspiracy" by the CPI(M) and the BJP to "sabotage" the ongoing pilgrimage to Sabarimala temple.

"While Desai is having Sangh Parivar connection, Ammini is a supporter of the CPI(M). Both of them have come to climb Sabarimala hills. This is a move to sabotage Sabarimala pilgrimage," he alleged.

The senior Congress leader also urged the government to take steps to maintain peace and sanctity of the temple.

Comments

abbu
 - 
Wednesday, 27 Nov 2019

RSS.. DEVOTEESS SHOULD OBEY THE SUPREME COURT VERDICT....... AND ALLOW WOMENS TO VISIT SABARIMALA TEMPLE........... SAME AS THEY ARE ADVISING MUSLIMS TO OBEY THE VERDICT OF BABRI MASJID....... FIRST YOU ACCEPT THE VERDICT OF SABARIMALA AND THEN MUSLIMS  WILL ALSO ACCEPT

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 12,2020

New Delhi, Jul 12: With the highest single-day spike of 28,637 new cases and 551 deaths being reported in the last 24 hours, India's COVID-19 count reached 8,49,553 on Sunday.

According to the Union Health and Family Welfare Ministry, this includes 2,92,258 active cases, and 5,34,621 cured and discharged or migrated patients. The toll due to the disease has reached 22,674 in the country.

Maharashtra with 2,46,600 cases continues to be the worst affected state by COVID-19 in the country. The state has 99,499 active cases while 1,36,985 patients have been cured and discharged so far. The death toll due to the disease now stands at 10,116.

Tamil Nadu with 1,34,226 cases, including 46,413 active ones, is the next worst affected in the country. While the number of cured and discharged patients is at 85,915 in the state, the toll due to the disease is at 1,898.

The national capital has recorded 1,10,921 confirmed cases so far. However, the number of active cases in Delhi is at 19,895 and 87,692 patients have been cured and discharged so far. With 3,334 deaths being reported due to COVID-19 in the city. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 19,2020

New Delhi, Mar 19: Lawyer of Mukesh Singh, who is one of the four death row convicts in the Nirbhaya gang-rape and murder case, on Thursday mentioned a petition before the Registrar of the Supreme Court seeking an urgent hearing in the matter.

Advocate Manohar Lal Sharma, through the petition, sought directions to bring call record, documents and reports of his client through any probe agency and passed appropriate directions and measure to ensure justice in the matter.

The petition, however, has not sought a stay on the execution, which is scheduled for the morning of March 20. The petition is likely to be taken up for hearing today.

Earlier today, the apex court dismissed the curative petition of Pawan Gupta, another convict in the matter, who claimed juvenility at the time of the crime.

This comes as the four convicts -- Mukesh Singh, Akshay Singh Thakur, Vinay Sharma and Pawan Gupta -- are scheduled to be hanged at 5.30 am on March 20.

Meanwhile, several other petitions are also pending in the matter in different courts.

The case pertains to the brutal gang-rape and killing of a 23-year-old paramedical student in a moving bus on the night of December 16, 2012, by six people including a juvenile in the national capital. The woman had died at a Singapore hospital a few days later.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.